Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole Once Monthly Re-hospitalization Study in Schizophrenia
NCT02717130Terminated
- Sponsor
- Florida Atlantic University
- Start
- Jun 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of aripiprazole in schizophrenia, sponsored by Florida Atlantic University. Primary endpoint: Assessment of Hospital Re-admission in a 30 Day Time Frame. Started Jun 2016; status: terminated.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02717130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02717130.